Cargando…
MK2: an unrecognized regulator of tumor promoting macrophages in colorectal cancer?
Colorectal cancer (CRC) is one of the most common malignancies and is associated closely with inflammation before and after development. Macrophages promote colitis and colitis-associated CRC. M1 macrophages contribute to colitis directly through the production of proinflammatory cytokines and throu...
Autores principales: | Castillo, Eliseo F., Ray, Anita L., Beswick, Ellen J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4798244/ https://www.ncbi.nlm.nih.gov/pubmed/26998523 http://dx.doi.org/10.14800/macrophage.1166 |
Ejemplares similares
-
MK2 Regulates Macrophage Chemokine Activity and Recruitment to Promote Colon Tumor Growth
por: Phinney, Brandon B., et al.
Publicado: (2018) -
MK2 Promotes the Development and Progression of Pancreatic Neuroendocrine Tumors Mediated by Macrophages and Metabolomic Factors
por: Jacenik, Damian, et al.
Publicado: (2022) -
Anti-G-CSF treatment induces protective tumor immunity in mouse colon cancer by promoting NK cell, macrophage and T cell responses
por: Morris, Katherine T., et al.
Publicado: (2015) -
Cooperative and distinct functions of MK2 and MK3 in the regulation of the macrophage transcriptional response to lipopolysaccharide
por: Ehlting, Christian, et al.
Publicado: (2019) -
MK2 Inhibitors as a Potential Crohn’s Disease Treatment Approach for Regulating MMP Expression, Cleavage of Checkpoint Molecules and T Cell Activity
por: Lebish, Eric J., et al.
Publicado: (2022)